Terms: = Ovarian cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
18 results:
1. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing.
Keyhanian K; Han L; Howitt BE; Longacre T
Am J Surg Pathol; 2024 Mar; 48(3):292-301. PubMed ID: 38062789
[TBL] [Abstract] [Full Text] [Related]
2. Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma.
Zaitsu S; Yano M; Adachi S; Miwa M; Katoh T; Kawano Y; Yasuda M
J Ovarian Res; 2023 May; 16(1):93. PubMed ID: 37179337
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer.
Chung YS; Kim Y; Kim HS; Lee JY; Kang WJ; Kim S; Kim SW
J Gynecol Oncol; 2022 May; 33(3):e28. PubMed ID: 35128858
[TBL] [Abstract] [Full Text] [Related]
4. Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.
Ovilla-Martinez R; Weber Sánchez LA; Cota-Rangel X; Baez-Islas PE
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764108
[TBL] [Abstract] [Full Text] [Related]
5. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
Oliveira T; Zhang M; Joo EJ; Abdel-Azim H; Chen CW; Yang L; Chou CH; Qin X; Chen J; Alagesan K; Almeida A; Jacob F; Packer NH; von Itzstein M; Heisterkamp N; Kolarich D
Theranostics; 2021; 11(19):9519-9537. PubMed ID: 34646384
[TBL] [Abstract] [Full Text] [Related]
6. ovarian Sparing Surgery in Mature ovarian Teratomas in Children: A 20-Year Single-Center Experience.
Szymon O; Bogusz B; Taczanowska-Niemczuk A; Maślanka M; Górecki W
Eur J Pediatr Surg; 2021 Feb; 31(1):2-7. PubMed ID: 32950035
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of volume-based metabolic parameters of
Han S; Kim H; Kim YJ; Suh CH; Woo S
Ann Nucl Med; 2018 Dec; 32(10):669-677. PubMed ID: 30101392
[TBL] [Abstract] [Full Text] [Related]
8. EphB3 protein is associated with histological grade and FIGO stage in ovarian serous carcinomas.
Gao W; Zhang Q; Wang Y; Wang J; Zhang S
APMIS; 2017 Feb; 125(2):122-127. PubMed ID: 28120491
[TBL] [Abstract] [Full Text] [Related]
9. The clinical significance of vascular endothelial growth factor in malignant ascites.
Zhan N; Dong WG; Wang J
Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
[TBL] [Abstract] [Full Text] [Related]
10. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.
Iglesia MD; Vincent BG; Parker JS; Hoadley KA; Carey LA; Perou CM; Serody JS
Clin Cancer Res; 2014 Jul; 20(14):3818-29. PubMed ID: 24916698
[TBL] [Abstract] [Full Text] [Related]
12. Therapy-related myelodysplasia and acute myeloid leukemia.
Bhatia S
Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
[TBL] [Abstract] [Full Text] [Related]
13. The clinical behavior of 124 leukemic ovarian tumors: clues for improving the poor prognosis.
Cunningham I
Leuk Lymphoma; 2013 Jul; 54(7):1430-6. PubMed ID: 23167607
[TBL] [Abstract] [Full Text] [Related]
14. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
[TBL] [Abstract] [Full Text] [Related]
15. An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.
Noske A; Schwabe M; Weichert W; Darb-Esfahani S; Buckendahl AC; Sehouli J; Braicu EI; Budczies J; Dietel M; Denkert C
BMC Cancer; 2011 Jul; 11():294. PubMed ID: 21756326
[TBL] [Abstract] [Full Text] [Related]
16. Integrative genomic analyses on Ikaros and its expression related to solid cancer prognosis.
Yang L; Luo Y; Wei J
Oncol Rep; 2010 Aug; 24(2):571-7. PubMed ID: 20596648
[TBL] [Abstract] [Full Text] [Related]
17. Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.
Watari H; Hosaka M; Mitamura T; Moriwaki M; Ohba Y; Todo Y; Takeda M; Ebina Y; Sakuragi N
Eur J Gynaecol Oncol; 2008; 29(6):573-7. PubMed ID: 19115681
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract] [Full Text] [Related]
